Get the Stockscreener App
2.35
4.08%
-0.10
Nexalin Technology Inc stock is traded at $2.35, with a volume of 22,228.
It is down -4.08% in the last 24 hours and down -52.24% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$2.45
Open:
$2.44
24h Volume:
22,228
Relative Volume:
0.17
Market Cap:
$2.46M
Revenue:
$275.60K
Net Income/Loss:
$-8.33M
P/E Ratio:
-5.0877
EPS:
-0.4619
Net Cash Flow:
$-5.40M
1W Performance:
-35.26%
1M Performance:
-52.24%
6M Performance:
-83.14%
1Y Performance:
-94.11%
1-Day Range:
$2.28
$2.51
1-Week Range:
$2.10
$3.7585
52-Week Range:
$2.10
$50.70
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
2.35 | 2.46M | 275.60K | -8.33M | -5.40M | -0.4619 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc Stock (NXL) Latest News
IPO Databook: Nexalin Technology (NXL US)Oct 2026 - Smartkarma
Form S-1/A Nexalin Technology Inc For: 9 October By Investing.com - Investing.com Canada
Form S-1/A Nexalin Technology Inc For: 9 October By Investing.com - Investing.com India
Nexalin Technology regains compliance with Nasdaq requirement - TipRanks
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing - markets.businessinsider.com
Nexalin Technology notifies Nasdaq compliance on minimum bid price - TradingView
Nexalin Technology Regains Compliance with Nasdaq Minimum - GlobeNewswire
Nexalin Regains Nasdaq Compliance Amid Ongoing Listing Risks - TipRanks
Why Is Nexalin Technology Stock Gaining Thursday? - Benzinga
Nexalin Technology, Inc. (NXL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nexalin Technology Granted Conditional Nasdaq Listing Extension - The Globe and Mail
NXL S-8 & SEC Filings - Yahoo! Finance Canada
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - ACCESS Newswire
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - The Batesville Daily Guard
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - Yahoo Finance
Lands' End (NASDAQ: LE) tech chief reports zero stock - Stock Titan
Nexalin Technology (NXL) Slips 3.94% to $4.85 as Shares Drift Toward Lower SupportVolume Breakout Ideas - dars.gov.et
Nexalin Technology (NXL) Declines 5.34% to $4.79, Pressuring Key Support LevelSupply Zone - siam.in
Nexalin Technology registers to sell 5.75M shares of common stock for holders - TipRanks
Multi-million-share resale could boost Nexalin (NASDAQ: NXL) share count - Stock Titan
Greenlight Ventures Discloses Investment at Nexalin Technology with 5.6% Stake - TradingView
Stock-for-deal investor steps in at Nexalin (NASDAQ: NXL) - Stock Titan
Nexalin Technology (NASDAQ: NXL) Announces Carolyn Shelton's Exit with $20,000 Bonus and Accelerated Stock Option Vesting - kalkinemedia.com
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to - Yahoo Finance
ZoomInfo (GTM) 10% holder moves 4,575 shares for employee taxes - Stock Titan
Nexalin Technology Announces Key Executive Leadership Departure - TipRanks
Carolyn Shelton exits Nexalin as Senior VP; separation terms include bonus and option vesting - TradingView
Nexalin Technology, Inc. Announces Resignation of Carolyn Shelton from Senior Vice President of Quality, Regulatory, and Clinical Affairs, Effective August 28, 2026 - marketscreener.com
ZoomInfo (GTM) insider lines up 94-share stock sale - Stock Titan
Alumni Capital LP Holds 9.99% Stake in Nexalin Technology (NASDAQ: NXL), Disclosing 2.49 Million Shares - kalkinemedia.com
Nexalin Technology approves 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Nexalin Technology approves 1-for-30 reverse stock split By Investing.com - Investing.com UK
Nexalin Technology Announces Reverse Stock Split - GlobeNewswire
Nexalin Technology (NXL) draws new near-10% investor stake - Stock Titan
Nexalin Technology approves 1-for-30 reverse stock split - Investing.com
Nexalin Technology Announces Reverse Stock Split - Yahoo Finance
Nexalin Technology Announces Reverse Stock Split - markets.businessinsider.com
Nexalin Technology Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Compliance - Quiver Quantitative
Nexalin will combine every 30 shares into one at 5 p.m. Aug. 28 - Stock Titan
Amprius (NYSE: AMPX) director offloads shares in tax-driven sale - Stock Titan
Nexalin Technology Raises Liquidity via Short-Term Note - TipRanks
Nexalin Technology Issues $1.17 Million OID Note for $1.0 Million Proceeds - TradingView
Nexalin Announces Capital Raise and Flexible Equity Facility - TipRanks
Nexalin Technology Raises $750,000 in Registered Direct Offering - minichart.com.sg
Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital - TradingView
Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingEPS Guidance Update - dars.gov.et
Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingTech Earnings Analysis - vinanet.vn
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - The Globe and Mail
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - TipRanks
Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.19%
22.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):